Literature DB >> 3466904

Effects of N-methyl-thiotetrazole cephalosporin on haemostasis in patients with reduced serum vitamin K1 concentrations.

I J Mackie, K Walshe, H Cohen, P McCarthy, M Shearer, S D Scott, S J Karran, S J Machin.   

Abstract

Two patients with low random serum vitamin K1 concentrations but with normal prothrombin times and normal biological assays of the vitamin K dependent coagulation proteins were treated with an N-methyl-thiotetrazole cephalosporin (cefotetan) postoperatively. Four to six days later both patients developed a prolonged prothrombin time and a noticeable and specific lowering of the clotting activities of factors II, VII, IX and X, though the serum vitamin K1 concentrations remained unchanged. Crossed immunoelectrophoresis of prothrombin showed the appearance of a second peak corresponding to descarboxyprothrombin (PIVKA II). These abnormalities corrected after vitamin K administration. These data are consistent with the hypothesis that cephalosporins with an N-methyl-thiotetrazole side chain inhibit the hepatic utilisation of vitamin K but that this only causes hypoprothrombinaemia when liver reserves of vitamin K are low.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3466904      PMCID: PMC1140772          DOI: 10.1136/jcp.39.11.1245

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  Hypoprothrombinemia caused by cephalosporins.

Authors:  K Andrassy; H Bechtold; E Ritz
Journal:  J Antimicrob Chemother       Date:  1985-02       Impact factor: 5.790

2.  Stability of beta-lactam antibiotics containing N-methylthiotetrazole side-chain.

Authors:  R Wise; J Dent
Journal:  Lancet       Date:  1983-09-10       Impact factor: 79.321

3.  Vitamin K-dependent proteins.

Authors:  P A Friedman
Journal:  N Engl J Med       Date:  1984-05-31       Impact factor: 91.245

4.  Evidence for impaired hepatic vitamin K1 metabolism in patients treated with N-methyl-thiotetrazole cephalosporins.

Authors:  H Bechtold; K Andrassy; E Jähnchen; J Koderisch; H Koderisch; L S Weilemann; H G Sonntag; E Ritz
Journal:  Thromb Haemost       Date:  1984-07-29       Impact factor: 5.249

5.  Hypoprothrombinemia and platelet dysfunction caused by cephalosporin and oxalactam antibiotics.

Authors:  C R Smith; J J Lipsky
Journal:  J Antimicrob Chemother       Date:  1983-06       Impact factor: 5.790

6.  The effects of latamoxef, cefotaxime, and cefoperazone on platelet function and coagulation in normal volunteers.

Authors:  M R Weitekamp; G M Caputo; H A Al-Mondhiry; R C Aber
Journal:  J Antimicrob Chemother       Date:  1985-07       Impact factor: 5.790

7.  The prevalence of vitamin K deficiency in chronic gastrointestinal disorders.

Authors:  S D Krasinski; R M Russell; B C Furie; S F Kruger; P F Jacques; B Furie
Journal:  Am J Clin Nutr       Date:  1985-03       Impact factor: 7.045

8.  A high incidence of bleeding is observed in a trial to determine whether addition of metronidazole is needed with latamoxef for prophylaxis in colorectal surgery.

Authors:  D L Morris; P J Fabricius; N S Ambrose; B Scammell; D W Burdon; M R Keighley
Journal:  J Hosp Infect       Date:  1984-12       Impact factor: 3.926

9.  Mechanism of the inhibition of the gamma-carboxylation of glutamic acid by N-methylthiotetrazole-containing antibiotics.

Authors:  J J Lipsky
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

10.  Vitamin K requirements in patients receiving total parenteral nutrition.

Authors:  L J Hands; G T Royle; M G Kettlewell
Journal:  Br J Surg       Date:  1985-08       Impact factor: 6.939

View more
  4 in total

1.  Platelet function and coagulation in patients with hepatobiliary disorders receiving cefotetan prophylaxis.

Authors:  D R Triger; R G Malia; F E Preston
Journal:  Infection       Date:  1988 Mar-Apr       Impact factor: 3.553

2.  Comparative evaluation of the pharmacokinetics of N-methylthiotetrazole following administration of cefoperazone, cefotetan, and cefmetazole.

Authors:  L S Welage; M T Borin; J H Wilton; L G Hejmanowski; P B Wels; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

3.  Antibiotic treatment and associated prolonged prothrombin time.

Authors:  K J Williams; R P Bax; H Brown; S J Machin
Journal:  J Clin Pathol       Date:  1991-09       Impact factor: 3.411

4.  Comparison of N-methylthiotetrazole dispositions in healthy volunteers following single intravenous doses of moxalactam, cefoperazone, and cefotetan.

Authors:  L S Welage; L G Hejmanowski; J H Wilton; C Walawander; D Rigan; J S Williams; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.